摘要:
Amide compounds of the formula: wherein R1 and R2 are taken together to form lower alkenylene, etc., R3 is aryl, etc., X is N, etc., Y is a single bond, etc., and Q is and salt thereof, which are useful as medicament.
摘要:
Amide compounds of the formula: wherein R1 and R2 are taken together to form lower alkenylene, etc., R3 is aryl, etc., X is N, etc., Y is a single bond, etc., and Q is and salt thereof, which are useful as medicament.
摘要:
Amide compounds of the formula: wherein R1 and R2 are taken together to form lower alkenylene, etc., R3 is aryl, etc., X is N, etc., Y is a single bond, etc., and Q is and salt thereof, which are useful as medicament.
摘要:
Amide compounds of the formula: wherein R1 and R2 are taken together to form lower alkenylene, etc., R3 is aryl, etc., X is N, etc., Y is a single bond, etc., and Q is and salt thereof, which are useful as medicament.
摘要:
This invention relates to amide compounds having the potentiation of the cholinergic activity and represented by formula (I) wherein R1 is acyl, R2 is lower alkyl, A is a single bond, —CO— or —SO2—, E is lower alkylene, X is CH or N, Y is a single bond, Q is —CH2— etc. and R3 and R4 are taken together to form lower alkylene etc., pharmaceutically acceptable salts and processes fro preparation thereof and a pharmaceutical composition comprising the same.
摘要:
A mobile communication method according to the present invention includes a step of transmitting, by a radio base station DeNB, “RA Response” to a mobile station UE within a “RA Response window” for the mobile station UE when “RA Preamble” is received from the mobile station UE, a step of transmitting, by a relay node RN, a signal to the mobile station UE in a subframe other than an MBSFN subframe, and a step of transmitting, by the radio base station DeNB, “RA Response” to the relay node RN in an MBSFN subframe of a “RA Response window” for the relay node RN when “RA Preamble” is received from the relay node RN.
摘要:
A recording apparatus including a recording head that discharges UV ink onto a recording material and an ultraviolet light irradiation unit that irradiates ultraviolet light to the discharged UV ink so as to harden the UV ink; further includes a failure diagnostic unit that diagnoses a failure condition of the ultraviolet light irradiation unit and a controller that controls operations of the recording head, the ultraviolet light irradiation unit, and the failure diagnostic unit. Further, the controller is so configured as to change the operation mode of the recording apparatus to a failure-state mode when the ultraviolet light irradiation unit has been diagnosed as a failure by the failure diagnostic unit.
摘要:
A nozzle holder 34 includes a nozzle base 51 whose both ends are supported, the nozzle base 51 inside which a vacuum path is formed, extending in a horizontal direction, a nozzle locking member 53 for communicating a nozzle 20a to the vacuum path (vacuum path 72 of the inside of the nozzle base) of the inside of the nozzle base 51, and a pair of fixing members 54 for fixing the nozzle locking member 53 to the nozzle base 51.
摘要:
A base station generates first setting information commonly used for establishing a logical path for communication with a user apparatus and for establishing a logical path for communication with a relay station, and second setting information used only for establishing the logical path for communication with the relay station, and transmits a second RRC message including the second setting information to the relay station after transmitting a first RRC message including the first setting information to the relay station. The first setting information includes information indicating a priority of a radio bearer in the logical path, information indicating usage of resources in SPS, information indicating resources of SRS, configuration information in a MAC sublayer, and information on change of a security encryption key in handover, and the second setting information includes at least system information and MBSFN information.
摘要:
A composition for treating cancer, comprising 6 to 13 peptides derived from tumor antigens, wherein the composition is used in the manner that antibodies to the respective peptides in the peripheral blood of a patient are measured and peptides to which antibodies are positive are selected and administered to the patient, and a peptide selection method.